tirzepatide y semaglutide vs Semaglutide vs. Tirzepatide: Which GLP-1

As far as we are aware, ongoing clinical trials are mainly looking at the effects of SGLT2 inhibitors in obese subjects without diabetes as a monotherapy (NCT03710460

Science Snapshot A 2021 study in The New England Journal of Medicine found semaglutide led to 15% weight loss but caused muscle loss in 30% of participants (link)

The weekly injection is FDA-approved to help people struggling with their weight and/or weight-related health conditions to lose weight and improve their overall health

Well, that depends on various factors and varies from person to person

Adjusting nutrition, exercise, or dosage under medical guidance can help manage plateaus.